8-K: ParkerVision Secures $3.46M in Common Stock Sale

ParkerVision, Inc. announced the closing of a $3.46 million common stock sale to accredited and institutional investors.

Summary

• ParkerVision, Inc. closed the sale of 16,481,579 shares of its common stock.
• The shares were sold at a price of $0.21 per share, generating gross proceeds of approximately $3.46 million.
• The sale was made to accredited and institutional investors as a registered direct offering.
• The offering was conducted under the Company's Shelf Registration statement, which was filed in April 2025 and declared effective by the SEC on May 28, 2025.
• To date, the Company has raised an aggregate of approximately $4.46 million under its Shelf Registration, including $1 million in common stock sold to a director on November 17, 2025, also at $0.21 per share.
• The Company did not engage any underwriters, placement agents, brokers, or finders in connection with this specific $3.46 million transaction and paid no commissions or fees.

Sentiment

Score: 7

Explanation: The successful completion of a capital raise provides necessary funding for operations, including ongoing patent enforcement actions, without incurring underwriting fees for this specific transaction. However, it also results in shareholder dilution.

Positives

• Successfully raised approximately $3.46 million in gross proceeds, enhancing liquidity.
• The Company avoided paying commissions or fees for this specific transaction by not engaging underwriters, placement agents, brokers, or finders.
• The capital raise demonstrates investor confidence from accredited and institutional investors.
• The funding supports ongoing operations, including the Company's patent enforcement actions.

Negatives

• The issuance of 16,481,579 new shares of common stock results in dilution for existing shareholders.

Risks

• Actual results may differ materially due to market conditions and other risks discussed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2024, and subsequent filings.
• Forward-looking statements are based on current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The press release contains forward-looking statements based on current expectations and assumptions, which involve known and unknown risks and uncertainties that could cause actual results to differ materially. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

Management Comments

• Cynthia French (Chief Financial Officer) and Tony Vignieri (Communications Director) are listed as contacts for the company.

Industry Context

ParkerVision operates in the radio-frequency (RF) technology sector, focusing on inventing, developing, and licensing proprietary technologies. A significant part of its business model involves patent enforcement actions to protect its intellectual property. This capital raise provides essential funding to support these operations and ongoing litigation efforts, which are crucial for a company primarily focused on IP monetization.

Legal Proceedings

• ParkerVision, Inc. is engaged in a number of patent enforcement actions in the U.S. to protect patented rights that it believes are being broadly infringed upon by others.

Related Party Transactions

• The Company sold $1 million in common stock to a director on November 17, 2025, at a purchase price of $0.21 per share, as part of the aggregate capital raised under the Shelf Registration.

Stakeholder Impact

• Shareholders: Experience dilution due to the issuance of new common stock.
• Company: Gains significant liquidity to fund operations and strategic initiatives, particularly patent enforcement.
• New Investors: Opportunity to acquire common stock at $0.21 per share.

Next Steps

• The Company will file a prospectus supplement with the Securities and Exchange Commission on November 24, 2025, containing the final terms of the offering.

Key Dates

Recommendation

The capital raise provides essential funding for ParkerVision's operations, particularly its patent enforcement actions, which are critical to its business model. While it addresses immediate liquidity needs and avoids underwriting fees for this specific transaction, the issuance of new shares results in dilution for existing shareholders. The company's long-term prospects remain tied to the success of its patent litigation, which carries inherent uncertainties. Therefore, a 'hold' recommendation is appropriate as this event maintains the status quo by providing necessary capital without fundamentally altering the risk/reward profile in the short term.

Keywords

ParkerVision, PRKR, common stock offering, capital raise, equity financing, registered direct offering, RF technology, patent enforcement, accredited investors